The ability of MG132 to increase Ikaros expression in both whole and CD3+ T cell enriched splenocytes provided evidence that the ubiquitin proteasome pathway may regulate Ikaros expression in immune cells in our pancreatic cancer mouse model. The gene discussed is IKZF1; the disease is pancreatic neoplasm.